Epigenetic Regulator PHF8 Drives Cancer Progression and Presents New Therapeutic Target
A scientific review outlines how histone demethylase PHF8 drives cancer progression and highlights modern strategies to develop targeted therapies.
A scientific review outlines how histone demethylase PHF8 drives cancer progression and highlights modern strategies to develop targeted therapies.
Chemically modified BRD4 degraders MZ-1-ME and SIM-1-ME showed enhanced protein degradation and growth inhibition in a KSHV-infected endothelial cell model ...
A proof-of-concept nanoparticle system used hyaluronic acid for CD44-mediated tumor-cell targeting and glutathione-triggered disassembly to release ARV-771 and enable BRD4 ...
A PROTAC that degrades EP300 combined with AKT inhibition slowed tumor growth and extended survival in patient-derived osteosarcoma mouse models, ...
A new review details how ESR1 mutations, bypass signaling, and cell-cycle escape drive endocrine resistance in the most common breast ...
A new iScience study shows that the RNA acetyltransferase NAT10 stabilizes PCSK9 mRNA through N4-acetylcytidine modification, driving the osteogenic transformation ...
New research shows that loss of the tumour suppressor LATS1 on chromosome 6q drives Hippo pathway dysregulation in ultra-high-risk PFA ...
High-throughput proteomics and machine learning revealed that cereblon-recruiting androgen receptor degraders inhibit mitochondrial complex I, and guided linker modifications that ...
Fluorescent live-cell reporters reveal that the protein FKBP12 acts as a gatekeeper deciding which TGF-β superfamily ligands activate SMAD signaling ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.